Ocular Therapeutix™ Reports Fourth Quarter and Year End 2018 Financial Results and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Ocular Therapeutix™ Reports Fourth Quarter and Year End 2018 Financial Results and Business Update

Ocular Therapeutix (OCUL) Misses Q4 EPS by 4c

March 7, 2019 4:19 PM EST

Ocular Therapeutix (NASDAQ: OCUL) reported Q4 EPS of ($0.42), $0.04 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $504 thousand versus the consensus estimate of $480 thousand.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

... More